Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062043
Filing Date
2023-11-09
Accepted
2023-11-09 16:10:35
Documents
75
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ivvd-20230930.htm   iXBRL 10-Q 2579247
2 EX-10.2 ivvd-ex10_2.htm EX-10.2 59606
3 EX-10.3 ivvd-ex10_3.htm EX-10.3 352410
4 EX-31.1 ivvd-ex31_1.htm EX-31.1 20592
5 EX-31.2 ivvd-ex31_2.htm EX-31.2 20364
6 EX-32.1 ivvd-ex32_1.htm EX-32.1 12553
7 EX-32.2 ivvd-ex32_2.htm EX-32.2 12119
  Complete submission text file 0000950170-23-062043.txt   9472900

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ivvd-20230930_pre.xml EX-101.PRE 350234
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ivvd-20230930_cal.xml EX-101.CAL 40689
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ivvd-20230930_def.xml EX-101.DEF 189761
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ivvd-20230930.xsd EX-101.SCH 61007
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ivvd-20230930_lab.xml EX-101.LAB 471810
69 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20230930_htm.xml XML 1650670
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40703 | Film No.: 231392478
SIC: 2836 Biological Products, (No Diagnostic Substances)